Latest return on equity

Moleculin Biotech Return on equity

Direct answer

Moleculin Biotech's return on equity is -1,371.64%.

The verified market snapshot reports -1,371.64%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 12, 2026.

Get free Moleculin Biotech email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Return on equity
-1,371.64%